trial · primary record
TURALIO(R)
Neurofibroma, Plexiform
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 54 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Phase I: determine a phase II dose of TURALIO(R) |
| Registry ID | NCT02390752 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:09.163Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02390752
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.